Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Surgery), By End User (Ambulatory Surgery Centers, H

Gastric Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028


The Global Healthcare 3D Printing Market, valued at USD 1204.09 million in 2022, is poised for substantial growth in the forecast period, with an anticipated CAGR of 13.63% through 2028. This market encompasses the application of 3D printing technology within the healthcare and medical sectors, offering a wide array of possibilities. Medical additive manufacturing, as it's known, leverages three-dimensional printing to revolutionize healthcare. It enables the creation of patient-specific implants, such as orthopedic, cranial, and dental implants, meticulously designed to fit an individual's anatomy, resulting in superior outcomes and reduced complications.

Furthermore, 3D printing is instrumental in the production of customized prosthetic limbs and various assistive devices, significantly improving comfort, function, and aesthetics for amputees and individuals with limb differences. Surgeons employ 3D-printed models of a patient's anatomy for preoperative planning, enhancing surgical precision, and facilitating practice of complex procedures before actual patient surgery.

In regenerative medicine, 3D bioprinting plays a transformative role in crafting living tissues and organs using bioink composed of cells. This technology holds the promise of addressing organ transplantation shortages and advancing research in drug testing and disease modeling.

Within dentistry, 3D printing is widely adopted for creating dental crowns, bridges, and orthodontic devices, streamlining the production of dental restorations with improved precision and efficiency. Moreover, personalized medications with precise dosages and release profiles are now feasible, benefiting patients with specific medication requirements.

The Global Healthcare 3D Printing Market reflects the marriage of 3D printing technology with healthcare and medical applications. It encompasses the utilization of 3D printers and materials to fabricate custom medical devices, prosthetics, implants, tissue and organ replicas, pharmaceuticals, and more. This innovative approach has the potential to transform various facets of healthcare.

One pivotal aspect is the ability to provide patient-specific solutions. Surgeons can create precise anatomical models for preoperative planning, enhancing surgical accuracy and reducing risks. Tailored implants and prosthetics, perfectly matched to an individual's unique anatomy, lead to improved patient outcomes.

Furthermore, 3D bioprinting is a promising frontier in regenerative medicine, exploring the creation of functional human tissues and organs using bioink composed of living cells. This holds the potential to address organ shortages and elevate transplantation success rates.

The market's growth is driven by several factors, including the increasing demand for personalized medical solutions, advancements in 3D printing technology, and heightened research and development activities within healthcare institutions. Nevertheless, challenges like regulatory approvals, material safety, and cost-effectiveness need to be addressed for broader adoption. Nonetheless, the global healthcare 3D printing market continues its expansion, offering innovative solutions that hold the potential to transform patient care and reshape medical practices.

Key Market Drivers

Rising Aging Population

The rising aging population is a significant demographic trend that has a profound impact on the Global Healthcare 3D Printing Market. As the world's population continues to age, there is a growing demand for healthcare solutions tailored to the unique needs of elderly individuals. This demographic shift is driving the adoption of 3D printing technology in various healthcare applications. For instance, the elderly often require orthopedic implants, dental restorations, and assistive devices like customized hearing aids and mobility aids. 3D printing allows for the rapid and cost-effective production of these devices, which can be tailored to individual anatomies and preferences, ensuring better fit and functionality. Moreover, as elderly individuals are more susceptible to certain medical conditions, including degenerative joint diseases and organ failures, the regenerative capabilities of 3D bioprinting hold immense promise in providing patient-specific tissue and organ replacements. Overall, the aging population represents a substantial market for healthcare 3D printing, as it addresses the increasing need for personalized and age-appropriate medical solutions, thereby improving the quality of life for elderly individuals and contributing to the growth of this innovative sector..

Increased Research and Development

The increased emphasis on research and development (R&D) activities is a pivotal factor in propelling the Global Healthcare 3D Printing Market forward. The relentless pursuit of innovation in 3D printing technologies, materials, and applications is expanding the horizons of medical additive manufacturing. Research institutions, academic centers, healthcare organizations, and industry players are investing significantly in R&D endeavors. These efforts aim to optimize the performance of 3D printers, enhance the biocompatibility of materials, and develop novel bioinks for 3D bioprinting. Furthermore, R&D initiatives focus on expanding the range of medical applications, from creating more complex and functional implants to advancing the field of regenerative medicine. Collaboration between multidisciplinary teams, including engineers, material scientists, biologists, and medical professionals, drives the development of cutting-edge solutions. The outcomes of these R&D efforts are driving the adoption of 3D printing in healthcare by improving precision, reducing costs, and broadening the scope of patient-specific medical devices and tissue engineering. Ultimately, the synergy between research and practice is at the core of advancing healthcare 3D printing, leading to transformative changes in patient care and the medical industry as a whole..

Surgical Planning

Surgical planning is a critical application within the Global Healthcare 3D Printing Market that is revolutionizing the way complex medical procedures are conducted. 3D printing technology enables the creation of highly detailed, patient-specific anatomical models based on medical imaging data such as CT scans and MRIs. These models provide surgeons with an invaluable tool for preoperative planning and visualization. Surgeons can examine and manipulate these 3D-printed models to gain a deeper understanding of a patient's unique anatomy, pathology, and the specific challenges they may encounter during surgery. This enhanced understanding allows for meticulous surgical plans, leading to increased precision, reduced operating room time, and ultimately improved patient outcomes. Complex surgeries, such as orthopedic procedures, craniofacial reconstructions, and cardiovascular interventions, particularly benefit from this technology. Surgical planning with 3D printing enhances the surgeon's ability to strategize and practice complex procedures, ultimately increasing surgical success rates and minimizing risks. As a result, it not only contributes to better patient care but also exemplifies how 3D printing is reshaping the landscape of healthcare, offering personalized solutions and enhancing medical professionals' capabilities.

Advancements in Technology

Advancements in technology are at the forefront of the Global Healthcare 3D Printing Market, driving innovation and expanding the scope of possibilities within the field. Over the years, there has been remarkable progress in various facets of 3D printing technology, contributing to its widespread adoption in healthcare. These advancements include the development of more precise and sophisticated 3D printers, capable of producing intricate medical devices and anatomical models with unparalleled accuracy. Additionally, advancements in biocompatible materials have expanded the range of applications, allowing for the fabrication of implants, prosthetics, and bio printed tissues that are safer and more compatible with the human body. Furthermore, software tools have evolved to enable seamless integration of medical imaging data, facilitating the creation of patient-specific models for surgical planning and customized medical solutions. The integration of artificial intelligence and machine learning algorithms is enhancing data analysis and optimizing 3D printing processes. These technological breakthroughs collectively empower healthcare professionals to provide more personalized, efficient, and effective care, improving patient outcomes and positioning healthcare 3D printing as a transformative force in modern medicine.

Key Market Challenges

Material Limitations

Material limitations are a critical restraining factor in the Global Healthcare 3D Printing Market. While 3D printing offers immense potential in healthcare, the availability and suitability of materials for medical applications remain a significant challenge. Biocompatibility, sterilizability, and material safety are paramount concerns when creating medical devices, implants, and tissue constructs. Although there have been advancements in the development of biocompatible materials, there is still a lack of a wide range of materials that meet the stringent requirements for use within the human body. Ensuring that materials do not trigger adverse reactions, inflammation, or toxicity is essential for patient safety. Additionally, sterilization is a crucial consideration to eliminate microbial contamination and ensure the sterility of 3D-printed medical products. Not all 3D printing materials can withstand standard sterilization processes, limiting their utility in critical medical applications. The limitations in materials also impact the durability and long-term performance of 3D-printed implants and devices, raising concerns about their reliability and longevity. Moreover, while some materials are biocompatible and sterilizable, they may have limitations in terms of mechanical properties, such as strength, flexibility, or wear resistance. These material properties are vital for ensuring that 3D-printed medical devices and implants can withstand the rigors of the human body and function effectively over time. Efforts are ongoing to develop new materials and improve existing ones to overcome these limitations. However, addressing material constraints remains a complex challenge that requires collaboration between material scientists, engineers, and healthcare professionals to ensure that 3D-printed medical solutions meet the stringent safety and performance standards demanded by the healthcare industry.

Intellectual Property Issues

Intellectual property (IP) issues are a significant consideration in the Global Healthcare 3D Printing Market. These issues arise due to the digital nature of 3D printing, where designs, digital files, and data are integral to the manufacturing process. IP concerns encompass several aspects: Digital Design Ownership: The creation of digital designs for 3D-printed medical devices and implants can be a complex process, often involving designers, engineers, and healthcare professionals. Determining the ownership and rights associated with these digital files can be challenging, leading to disputes over design ownership and royalties. Design Distribution: Sharing and distributing digital design files for 3D printing can lead to IP infringement concerns. Unauthorized access, sharing, or replication of these files without proper permissions can violate copyright laws and intellectual property rights. Patents and Licensing: Companies and inventors often hold patents related to specific 3D-printed medical technologies. Licensing these patents and negotiating fair terms for their use can be complex, especially when multiple parties are involved in the manufacturing and distribution of medical products. Data Security: Protecting sensitive patient data and proprietary research and development data used in 3D printing processes is crucial. Data breaches can lead to IP theft and jeopardize patient privacy. Regulatory Compliance: Compliance with regulatory requirements, such as the U.S. Food and Drug Administration (FDA) regulations, often involves safeguarding the integrity of digital data and demonstrating traceability and control over the manufacturing process. Failure to do so can result in regulatory non-compliance and legal consequences. Open-Source vs. Proprietary Designs: The choice between open-source and proprietary designs can impact IP issues. Open-source designs encourage collaboration and sharing but may raise questions about IP rights, while proprietary designs may protect IP but limit accessibility and innovation. Addressing these IP issues necessitates clear legal frameworks, standardized agreements, and a robust system for tracking and protecting digital design files and data. Collaboration between legal experts, industry stakeholders, and regulatory authorities is essential to navigate these complex challenges and ensure that the Global Healthcare 3D Printing Market can continue to innovate while respecting intellectual property rights and safeguarding patient data.

Key Market Trends

Telemedicine Integration

Telemedicine integration represents a significant trend in the Global Healthcare 3D Printing Market, driven by the convergence of digital health technologies. Telemedicine, the remote delivery of healthcare services, gained substantial momentum, particularly during the COVID-19 pandemic, as patients and healthcare providers sought safe and convenient ways to connect. In this context, 3D printing technology has found a complementary role. Telemedicine platforms are increasingly incorporating 3D printing capabilities, allowing healthcare professionals to remotely prescribe, design, and deliver 3D-printed medical devices and models to patients' homes. For example, orthopedic surgeons can assess a patient's condition through teleconsultations, and if a custom orthopedic implant or prosthetic is needed, the digital design can be transmitted to a local 3D printing facility for fabrication and subsequently delivered to the patient. This integration streamlines the process, reduces the need for in-person visits, and enhances patient access to personalized healthcare solutions, especially in remote or underserved areas. Furthermore, telemedicine's expansion creates opportunities for 3D printing companies to collaborate with telehealth providers, offering a seamless and patient-centric approach to care. As the telemedicine and 3D printing industries continue to evolve, this integration has the potential to revolutionize the accessibility and delivery of healthcare, reinforcing the role of 3D printing as a versatile and patient-focused solution within the global healthcare landscape.

Dental and Orthopedic Applications

Dental and orthopedic applications have been at the forefront of the Global Healthcare 3D Printing Market due to the profound impact of 3D printing technology on these fields. In dentistry, 3D printing has revolutionized the fabrication of dental prosthetics, crowns, bridges, and orthodontic devices. Dental laboratories and practices can now produce highly precise and patient-specific restorations, reducing turnaround times and enhancing overall treatment quality. The ability to scan a patient's oral anatomy and directly convert it into a digital design for 3D printing has streamlined the entire dental prosthetic manufacturing process. Moreover, orthodontics has benefited from 3D printing through the creation of customized clear aligners and braces, improving patient comfort and compliance. In orthopedics, 3D printing has made significant strides in the development of patient-specific implants, prosthetics, and surgical instruments. Orthopedic surgeons can use 3D printing to create personalized implants tailored to an individual's unique anatomy, resulting in better fit and improved outcomes for joint replacements or trauma cases. This customization reduces the risk of complications and enhances patient satisfaction. Additionally, orthopedic surgeons use 3D-printed anatomical models for preoperative planning, allowing for a deeper understanding of complex cases and enabling precise surgical procedures. Furthermore, orthopedic practices are exploring the potential of 3D printing for creating patient-specific bone grafts and tissue scaffolds, advancing regenerative medicine within the orthopedic field. These dental and orthopedic applications underscore the versatility and patient-centric nature of 3D printing in healthcare. They have paved the way for further innovation in the Global Healthcare 3D Printing Market and have demonstrated the technology's potential to improve patient care, reduce costs, and drive advancements in both dental and orthopedic fields.

Segmental Insights

Material Insights

In 2022, the Healthcare 3D Printing Market was dominated by the Metals and Alloy segment and is predicted to continue expanding over the coming years. This is attributed due to the rising prevalence of cancer across various regions in the world along with 3D-printed device for implants or other medical uses.

Regional Insights

In 2022, the Global Healthcare 3D Printing Market was dominated by the North America segment and is predicted to continue expanding over the coming years. This is ascribed due to rising cases cancer cases, rising development of cancer technology, and the growing healthcare infrastructure.

Key Market Players

Bio-Rad Laboratories

Guardant Health Inc.

Illumina, Inc.

Qiagen NV

Laboratory Corporation of America Holdings

F. Hoffmann-La Roche AG

Thermo Fisher Scientific Inc.

Johnson & Johnso

Biocept Inc.

Bio-Rad Laboratories, Inc.

Report Scope:

In this report, the Global Healthcare 3D Printing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
  • Global Healthcare 3D Printing Market, By Indication:
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Other Indications
  • Global Healthcare 3D Printing Market, By Type:
  • Circulating Tumor Cells
  • Circulating Tumor DNA
  • Cell-free DNA
  • Global Healthcare 3D Printing Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Healthcare 3D Printing Market.

Company Information
  • Detailed analysis and profiling of additional Market players (up to five).
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order. Single User license will be delivered in PDF format without printing rights


1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Global Gastric Cancer Therapy Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Surgery)
5.2.2. By End User (Ambulatory Surgery Centers, Hospitals and Specialty Clinics, and Other)
5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.4. By Company (2022)
5.3. Product Market Map
5.3.1. By Therapy Type
5.3.2. By End User
5.3.3. By Region
6. North America Gastric Cancer Therapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapy Type
6.2.2. By End User
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Gastric Cancer Therapy Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Therapy Type
6.3.1.2.2. By End User
6.3.2. Canada Gastric Cancer Therapy Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Therapy Type
6.3.2.2.2. By End User
6.3.3. Mexico Gastric Cancer Therapy Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Therapy Type
6.3.3.2.2. By End User
7. Europe Gastric Cancer Therapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapy Type
7.2.2. By End User
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Gastric Cancer Therapy Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Therapy Type
7.3.1.2.2. By End User
7.3.2. France Gastric Cancer Therapy Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Therapy Type
7.3.2.2.2. By End User
7.3.3. United Kingdom Gastric Cancer Therapy Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Therapy Type
7.3.3.2.2. By End User
7.3.4. Italy Gastric Cancer Therapy Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Therapy Type
7.3.4.2.2. By End User
7.3.5. Spain Gastric Cancer Therapy Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Therapy Type
7.3.5.2.2. By End User
8. Asia-Pacific Gastric Cancer Therapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapy Type
8.2.2. By End User
8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Gastric Cancer Therapy Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Therapy Type
8.3.1.2.2. By End User
8.3.2. Japan Gastric Cancer Therapy Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Therapy Type
8.3.2.2.2. By End User
8.3.3. India Gastric Cancer Therapy Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Therapy Type
8.3.3.2.2. By End User
8.3.4. South Korea Gastric Cancer Therapy Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Therapy Type
8.3.4.2.2. By End User
8.3.5. Australia Gastric Cancer Therapy Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Therapy Type
8.3.5.2.2. By End User
9. South America Gastric Cancer Therapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapy Type
9.2.2. By End User
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Gastric Cancer Therapy Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Therapy Type
9.3.1.2.2. By End User
9.3.2. Argentina Gastric Cancer Therapy Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Therapy Type
9.3.2.2.2. By End User
9.3.3. Colombia Gastric Cancer Therapy Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Therapy Type
9.3.3.2.2. By End User
10. Middle East and Africa Gastric Cancer Therapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Therapy Type
10.2.2. By End User
10.2.3. By Country
10.3. MEA: Country Analysis
10.3.1. UAE Gastric Cancer Therapy Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Therapy Type
10.3.1.2.2. By End User
10.3.2. Saudi Arabia Gastric Cancer Therapy Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Therapy Type
10.3.2.2.2. By End User
10.3.3. South Africa Gastric Cancer Therapy Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Therapy Type
10.3.3.2.2. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition
12.2. Product Development
12.3. Recent Developments
13. Porter’s analysis
14. PESTEL analysis
15. Clinical Trial Analysis
15.1. Ongoing Clinical Trials
15.2. Completed Clinical Trials
15.3. Terminated Clinical Trials
15.4. Breakdown of Pipeline, By Development Phase
15.5. Breakdown of Pipeline, By Status
15.6. Breakdown of Pipeline, By Study Application
15.7. Breakdown of Pipeline, By Region
15.8. Clinical Trials Heat Map
16. Competitive Landscape
16.1. Business Overview
16.2. Company Snapshot
16.3. Products & Services
16.4. Financials (As Reported)
16.5. Recent Developments
16.5.1. Abbott Laboratories Inc.
16.5.2. Amgen, Inc.
16.5.3. Celltrion Inc.
16.5.4. Novartis AG
16.5.5. F. Hoffmann-La Roche Ltd
16.5.6. Agilent Technologies Inc.
16.5.7. AstraZeneca Plc
16.5.8. Pfizer Inc.
16.5.9. Eli Lilly & Co.
16.5.10. GlaxoSmithKline Plc
17. Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings